Journal
FRONTIERS IN IMMUNOLOGY
Volume 13, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2022.979606
Keywords
plasmablast; CRISPR; Cas9; sgRNA libraries; plasmablast differentiation; NIPBL; MAU2
Categories
Funding
- Boehringer Ingelheim
- European Research Council (ERC) under the European Union [740349]
- Austrian Research Promotion Agency [FFG-878286]
- Boehringer Ingelheim Fonds PhD fellowship
- European Research Council (ERC) [740349] Funding Source: European Research Council (ERC)
Ask authors/readers for more resources
Plasma cells and plasmablasts are crucial for immune protection, and this study identified several new genes that are essential for plasmablast development through CRISPR-Cas9 screening.
Plasma cells (PCs) and their progenitors plasmablasts (PBs) are essential for the acute and long-term protection of the host against infections by providing vast levels of highly specific antibodies. Several transcription factors, like Blimp1 and Irf4, are already known to be essential for PC and PB differentiation and survival. We set out to identify additional genes, that are essential for PB development by CRISPR-Cas9 screening of 3,000 genes for the loss of PBs by employing the in vitro-inducible germinal center B cell (iGB) culture system and Rosa26(Cas9/+) mice. Identified hits in the screen were Mau2 and Nipbl, which are known to contribute to the loop extrusion function of the cohesin complex. Other examples of promising hits were Taf6, Stat3, Ppp6c and Pgs1. We thus provide a new set of genes, which are important for PB development.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available